Call(s) to Action: XXII, DGLY, NHTC, VRYAF The GeoTeam offers it own rebuttal to XXII’s response to GeoInvesting’s article, “22nd Century Group: A Lot Of Smoke, Not Enough Fire”. We disagree with the rebuttal by XXII’s management and stand by […]
Call(s) to Action: Stay tuned for our next short thesis report to be released later this morning. Here are the stories that the GeoTeam is following today… (Please see full disclosures at bottom) ChinaHybrids VIMC ($3.50) – Reported strong Q2 […]
Summary A number of factors lead us to the conclusion that 22nd Century Group (XXII) is severely overvalued and likely worth no more than $0.20 per share. In the past, the SEC charged XXII CEO Joseph Pandolfino, Jr. for stock […]
Call(s) to Action: CBAK ($3.78) – Q3 SEC filing provides more color on CBAK’s current financial state, disclosing that it lost its primary operating assets to foreclosure proceedings. The company is essentially approaching zero cash ($272,115) negative equity of $19.5 […]
Call(s) to Action: For the last couple of days, we have been highlighting Apptigo (APPG), an obvious Pump & Dump underway. Today, we are shooting to publish our take on the story since we are confident that the company’s shares […]
Apptigo International (APPG) is one of the most obvious pump and dump (P&D) cases we have come across since we began investigating P&D’s in our inaugural report Raystream (RAYS), which now trades at $0.001. Some of the characters associated with […]
Call(s) to Action: Please stay tuned for a report on two Pharmaceutical companies competing to use a cannabis-based compound to treat a specific condition in children. One of the companies is a bullish call, and the other bearish. Here are […]
Summary Cannabidiol (“CBD”), a cannabis-based substance, is the focus of INSY and GWPH, two companies competing to develop CBD for the treatment of Dravet Syndrome, a form of childhood epilepsy. Contrary to what appears to be respected analysts’ expectations, INSY […]